FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online September 24, 2004 as doi:10.1096/fj.04-2062fje.
Published as doi: 10.1096/fj.04-2062fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/15/1912
04-2062fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SÁENZ, D. A.
Right arrow Articles by ROSENSTEIN, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SÁENZ, D. A.
Right arrow Articles by ROSENSTEIN, R. E.
(The FASEB Journal. 2004;18:1912-1913.)
© 2004 FASEB

Effect of melatonin on the retinal glutamate/glutamine cycle in the golden hamster retina

DANIEL A. SÁENZ, ANDREA P. GOLDIN, LUCIANA MINCES, MÓNICA CHIANELLI, MARÍA I. KELLER SARMIENTO and RUTH E. ROSENSTEIN1

Laboratorio de Neuroquímica Retiniana y Oftalmología Experimental, Departamento de Bioquímica Humana, Facultad de Medicina, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina

1 Correspondence: Departamento de Bioquímica Humana, Facultad de Medicina, UBA. Paraguay 2155, 5°P, (1121), Buenos Aires, Argentina. E-mail: ruthr{at}fmed.uba.ar

SPECIFIC AIMS

The original aim of this study was to analyze the effect of melatonin on the glutamate/glutamine cycle activity in the hamster retina.

Glutamate is the main excitatory neurotransmitter in the retina but is neurotoxic when present in excessive amounts. The metabolic dependence of glutamatergic neurons on glia via the glutamate/glutamine cycle to provide the precursor for neurotransmitter glutamate is well established. An appropriate clearance of synaptic glutamate is required for normal function of retinal excitatory synapses and to prevent neurotoxicity. It was demonstrated that melatonin has a neuroprotective effect against glutamate-induced excitotoxicity in several systems. However, the full range of physiological actions and mechanisms involved in the effects of melatonin is not completely understood.

For the first time, we demonstrate in the present report that physiological concentrations of melatonin significantly modulate the retinal glutamate/glutamine cycle activity.

PRINCIPAL FINDINGS

  1. 1. Nanomolar concentrations of melatonin increased glutamine synthetase (GS) activity
  2. 2. Melatonin increased glutamine uptake (likely mediated by the A- and L- type transporter systems)
  3. 3. Melatonin significantly decreased glutaminase activity

CONCLUSIONS AND SIGNIFICANCE

Taken together, these results indicate that melatonin, probably through a redundant mechanism, may contribute to a decrease in synaptic glutamate concentrations. This effect could provide new insight into the neuroprotective potential of melatonin.

An increase in GS induced by glucocorticoids provides neuroprotection in different tissues, including the retina. Physiological levels of glucocorticoids regulate expression of this enzyme by stimulating transcription of the gene, taking ~24 h. This might explain why glucocorticoids must be supplied early to achieve a beneficial effect and suggests that only in programmed neurological interventions might prophylactic administration of glucocorticoids be advisable. In contrast, since the observed effect of melatonin was much faster, treatment with methoxyindole may circumvent this obstacle. Moreover, this beneficial effect of melatonin may be further improved by its effect on glutamate uptake, glutaminase activity, and the nitridergic pathway. In summary, these findings suggest that treatment with melatonin could be considered as a new approach to handling glutamate-mediated neuronal degeneration.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 1. Schematic representation of the retinal glutamate/glutamine cycle and its modulation by melatonin. Melatonin increased GS activity and glutamine uptake but decreased glutaminase activity. Positive effects of melatonin (M) are noted by an upward arrow; downward arrow indicates negative modulations. In earlier reports (*) we showed that melatonin inhibits nitric oxide synthase activity and increases glutamate uptake and release.

FOOTNOTES

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-2062fje;





This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/15/1912
04-2062fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SÁENZ, D. A.
Right arrow Articles by ROSENSTEIN, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SÁENZ, D. A.
Right arrow Articles by ROSENSTEIN, R. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS